Cell-mediated immunity of patients who have had basal cell carcinomas.

Authors

  • D Czarnecki
  • A Mar
  • E. Kulinskaya

DOI:

https://doi.org/10.2340/00015555762830

Abstract

The cell-mediated immunity of patients who had basal cell carcinomas (BCCs) removed was studied by measuring cuntaneous delayed hypersensitivity reactions to recall antigens (Multitest CMI, Pasteur-Merieux), and by measuring lymphocyte counts and subsets. One group of patients had multiple BCCs (3 or more) removed and were considered to have a high risk of new BCC formation. The other group consisted of patients who had one BCC and had not developed another within 5 years

Downloads

Download data is not yet available.

Downloads

Published

1996-01-01

How to Cite

Czarnecki, D., Mar, A., & Kulinskaya, E. (1996). Cell-mediated immunity of patients who have had basal cell carcinomas. Acta Dermato-Venereologica, 76(1), 28–30. https://doi.org/10.2340/00015555762830

Issue

Section

Articles